| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 1,590,637 | | Cost of Revenue |
-
| | | Gross Profit | 1,590,637 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 940,070 | | Non Recurring | 244,488 | | Others | 73,937 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 332,142 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (24,114) | | Earnings Before Interest And Taxes | 323,526 | | Interest Expense | 14,207 | | Income Before Tax | 309,319 | | Income Tax Expense | 193,371 | | Minority Interest | (92,391) | | | | Net Income From Continuing Ops | 23,557 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 23,557 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $23,557 |
|
0.34% Nasdaq 0.00%
Income Statement
